| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.2 (Miss by $-0.04) |
| EPS GAAP Actual | $0.2 (Miss by $-0.04) |
| Revenue Actual | $1.615B |
| Revenue Surprise | Beat by $1615M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.04172 |
| EPS GAAP Estimate | $1.04172 |
| Revenue Estimate | $1.63469578B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 3.62 | 3.46 | 3.50581 | 3.71286 | 1 |
| Dec 2026 | 5.18 | 2.42 | 5.03137 | 5.34012 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -2.54 | -3.74926 | 1.615B | 4.77% | -72.47M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 1.368B | 1.32% | 1368M |
| FQ4 2024 (Dec 2024) | -0.0534 | -0.0534 | 1.394B | 2.37% | 1394M |
| FQ3 2024 (Sep 2024) | -0.18 | -0.18 | 1.501B | 0.93% | 1501M |
| FQ2 2024 (Jun 2024) | 0.47 | 0.47 | 1.538B | -6.83% | 1538M |
| FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 1.35B | -13.78% | 1350M |
| FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 1.361B | 1.69% | 1361M |
| FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 1.487B | -19.5% | 1487M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.04172
Consensus Revenue Estimates
1.63469578B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.69 | -- | 0.63876 | 0.73777 | 1 |
| FQ3 2027 (Sep 2027) | 1.01 | -- | 0.935 | 1.07993 | 1 |
| FQ2 2027 (Jun 2027) | 1.17 | -- | 1.08312 | 1.25101 | 1 |
| FQ1 2027 (Mar 2027) | 0.74 | -- | 0.68505 | 0.79124 | 1 |
| FQ4 2026 (Oct 2026) | 1.5529 | -- | 1.49435 | 1.59331 | 1 |
| FQ3 2026 (Jul 2026) | 1.5889 | -- | 1.52899 | 1.63025 | 1 |
| FQ2 2026 (Jun 2026) | 1.6165 | 257.13 | 1.57864 | 1.65331 | 1 |
| FQ1 2026 (Mar 2026) | 1.0088 | 102.97 | 0.98517 | 1.03177 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.61B | -- | 1.51B | 1.69B | 1 |
| FQ3 2027 (Sep 2027) | 1.75B | -- | 1.65B | 1.84B | 1 |
| FQ2 2027 (Jun 2027) | 1.78B | -- | 1.68B | 1.88B | 1 |
| FQ1 2027 (Mar 2027) | 1.59B | -- | 1.5B | 1.68B | 1 |
| FQ4 2026 (Oct 2026) | 1.74B | -- | 1.69B | 1.78B | 1 |
| FQ3 2026 (Jul 2026) | 1.74B | -- | 1.69B | 1.78B | 1 |
| FQ2 2026 (Jun 2026) | 1.72B | 6.27 | 1.69B | 1.75B | 1 |
| FQ1 2026 (Mar 2026) | 1.55B | 11.79 | 1.52B | 1.58B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.20926 | -2.54 | -3.74926 | 147.61% |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0534 | -0.0534 | 100% | |
| FQ3 2024 (Sep 2024) | -0.18 | -0.18 | 100% | |
| FQ2 2024 (Jun 2024) | 0.47 | 0.47 | 100% | |
| FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 100% | |
| FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 100% | |
| FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.69B | $1.62B | $-72.47M | -4.49% |
| FQ1 2025 (Mar 2025) | $0B | $1.37B | $1368M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.39B | $1394M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.5B | $1501M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.54B | $1538M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.35B | $1350M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.36B | $1361M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.49B | $1487M | 100% |